Background: Few effective treatments exist for striae alba, which are the mature stage of stretch marks.

Objective: To evaluate the efficacy of the nonablative fractional 1,565-nm Erbium-glass (Er:glass) and the picosecond fractional 1,064/532-nm neodymium:yttrium-aluminum-garnet (Nd:YAG) lasers in the treatment of striae alba.

Materials And Methods: Twenty subjects with striae alba on the bilateral abdomen were treated with either the nonablative fractional 1565-nm Er:glass or the picosecond fractional 1,064/532-nm Nd:YAG laser, with a total of 3 treatments 3 weeks apart.

Results: A 31% (1.25/4) texture improvement was noted for both the fractional 1,565-nm Er:glass laser and the picosecond fractional 1,064/532-nm Nd:YAG laser. The degree of atrophy was improved by 30% (1.19/4) with the 1,565-nm Er:glass laser and 35% (1.38/4) with the picosecond 1,064/532-nm Nd:YAG laser. A 48% (1.9/4) subject overall assessment of improvement was noted with the fractional 1565-nm Er:glass laser and 45% (1.8/4) improvement with the picosecond fractional 1,064/532-nm Nd:YAG laser. There was no significant change in striae density with either laser. The picosecond laser was rated as less painful during all 3 sessions (p = .002) and had a shorter healing time (p = .035). The nonablative fractional 1,565-nm Er:glass and the picosecond fractional 1,064/532-nm Nd:YAG lasers were equally efficacious in improving striae alba.

Download full-text PDF

Source
http://dx.doi.org/10.1097/DSS.0000000000001555DOI Listing

Publication Analysis

Top Keywords

fractional 1565-nm
24
picosecond fractional
24
fractional 1064/532-nm
24
1565-nm erglass
20
1064/532-nm ndyag
20
nonablative fractional
16
striae alba
16
ndyag laser
16
fractional
12
erglass picosecond
12

Similar Publications

Article Synopsis
  • The 1565 nm non-ablative fractional laser is effective for skin rejuvenation, particularly for treating issues like stretch marks and acne scars, but can lead to temporary redness and swelling post-treatment.
  • A new method combines this laser with 30% super molecular salicylic acid to minimize side effects such as erythema and pigmentation.
  • The treatment involves specific steps, starting with tailored energy settings for the laser, followed by the application of salicylic acid until a frosty reaction indicates it's time to stop, aiming for a safer facial rejuvenation experience for patients.
View Article and Find Full Text PDF

Background: Acne vulgaris is a common inflammatory disease associated with various sequelae after skin lesion remission. Acne erythema has been considered simple erythema or a vascular lesion; however, because the understanding of this disease has improved, acne erythema is currently considered an early scar with erythematous components.

Aims: This study evaluated the efficacy of using both a 595-nm pulsed dye laser (PDL) and 1565-nm nonablative fractional laser (NAFL) for the treatment of erythematous scars caused by acne.

View Article and Find Full Text PDF

Comparison of the 1064-nm picosecond laser with fractionated microlens array and 1565-nm non-ablative fractional laser for the treatment of enlarged pores: a randomized, split-face, controlled trial.

Lasers Med Sci

February 2024

Department of laser surgery, Jiangsu Key Laboratory of Molecular Biology for Skin Diseases and STIs, Institute of Dermatology, Chinese Academy of Medical Sciences & Peking Union Medical College, Jiangwangmiao Street 12, Xuanwu District, Nanjing, 210042, China.

Article Synopsis
  • The study compared the effectiveness and safety of two different laser treatments—1064-nm picosecond laser with microlens array and 1565-nm nonablative fractional laser—on patients with enlarged facial pores.
  • Both lasers reduced pore size significantly after three treatment sessions, with no major differences in improvement scores or patient self-assessments between the two.
  • However, the picosecond laser was associated with less pain and a lower risk of hyperpigmentation compared to the nonablative fractional laser.
View Article and Find Full Text PDF

Background: Characterized by progressive hair loss due to an excessive response to androgens, androgenetic alopecia (AGA) affects up to 50% of males and females. Minoxidil is one of approved medications for AGA but inadequate responses occur in many patients.

Aims: To determine whether 1565 nm non-ablative fractional laser (NAFL) could yield better therapeutic benefits for patients with AGA as compared with 5% minoxidil.

View Article and Find Full Text PDF

Purpose: To evaluate the efficacy and safety of 1565-nm nonablative fractional laser (NAFL) combined with mucopolysaccharide polysulfate (MPS) cream in the treatment of erythematous acne scars.

Methods: A total of 28 subjects with erythematous acne scars from June 2021 to April 2022 were enrolled. One side of each subject's face was randomly assigned to be treated with 1565-nm NAFL (at 2 sessions with four-week intervals) combined with MPS cream (twice daily) for 8 weeks, and the other side with 1565-nm NAFL combined with placebo cream.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!